DRREDDY vs KOTAKBANK: Stock Comparison
Kotak Mahindra Bank Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a higher dividend yield and a higher ROCE, while Kotak Mahindra Bank Ltd shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 3; KOTAKBANK leads 9 of 12
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| Sector | Healthcare | Financial Services |
| Industry | Pharmaceuticals | Private Sector Bank |
Price
| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| Live Price | ₹1,206 | ₹392.4 |
| Day Change | 0.5% | 0.49% |
| Volume | 18 L | 57.27 L |
| 52-Week High | ₹1,414.9 | ₹453.2 |
| 52-Week Low | ₹1,101 | ₹345.5 |
| Distance from 52W High | -14.76% | -13.42% |
Valuation
| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| Market Cap | ₹1.01 L Cr | ₹3.89 L Cr |
| P/E Ratio | 31.05x | 19.22x |
| P/B Ratio | 2.64x | 2.15x |
| EPS | ₹39.77 | ₹20.27 |
| Book Value | ₹460.31 | ₹182.2 |
| Dividend Yield | 0.66% | 0.17% |
Growth
| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | -11% |
| EPS Growth (TTM YoY) | -86.2% | 9.8% |
| Qtr Sales Growth | -11.5% | 6.29% |
| Qtr Profit Growth | -86.1% | 4.53% |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| ROE | 11.2% | 11.4% |
| ROCE | 13% | 6.98% |
| Net Margin | 12.76% | 26.05% |
| Operating Margin | 19.2% | 21.9% |
| Debt to Equity | 0.2x | 3.65x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | KOTAKBANK |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 25.87% |
| FII Holding | 32.07%▼ 1.01 pp | 25.21%▼ 1.19 pp |
| DII Holding | 31.74%▲ 1.02 pp | 37.71%▲ 1.53 pp |
| Public Holding | 9.35%▲ 0.02 pp | 11.21%▼ 0.34 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Kotak Mahindra Bank Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.